Xconomy’s Digital Events →
Last month Symantec announced its plans to buy Blue Coat for $4.7 billion. Has the consolidation—and creation of this enterprise security giant—put immense pressure on other industry players? In an ideal... Read more »
Sponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
© 2007-2022, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.